Back to search

Article

Genetic Markers of Early Response to Lurasidone in Acute Schizophrenia

2023-11-16

Abstract excerpt

<title>Abstract</title> <p>Prediction of treatment response by genetic biomarkers has potential for clinical use and contributes to the understanding of pathophysiology and drug mechanism of action. The purpose of this study is to identify genetic biomarkers associated with response to lurasidone, an atypical antipsychotic drug, during the first four weeks of treatment. One-hundred and seventy-one acutely psychot...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6a17bebd-c639-5a10-84cc-dae6ecaa4a76
DOI
10.21203/rs.3.rs-3372085/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Genetic Markers of Early Response to Lurasidone in Acute SchizophreniaDOI 10.21203/rs.3.rs-3372085/v1
Genetic markers of early response to lurasidone in acute schizophrenia.Semantic proximity
Genetic predictors of antipsychotic response to lurasidone identified in a genome wide association study and by schizophrenia risk genes.Semantic proximity
Identifying the genetic risk factors for treatment response to lurasidone by genome-wide association study: A meta-analysis of samples from three independent clinical trials.Semantic proximity
Risperidone-induced changes in DNA methylation from peripheral blood in first-episode schizophrenia parallel neuroimaging and cognitive phenotypeSemantic proximity
Analysis of gene variants previously associated with iloperidone response in patients with schizophrenia who are treated with risperidone.Semantic proximity
Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients.Semantic proximity
The GRM7 gene, early response to risperidone, and schizophrenia: a genome-wide association study and a confirmatory pharmacogenetic analysis.Semantic proximity
Antipsychotic pharmacogenomics in first episode psychosis: a role for glutamate genes.Semantic proximity
Applicability of a genetic signature for enhanced iloperidone efficacy in the treatment of schizophrenia.Semantic proximity
Predicting Treatment Response in Schizophrenia With Magnetic Resonance Imaging and Polygenic Risk ScoreSemantic proximity
RGS4 polymorphisms predict clinical manifestations and responses to risperidone treatment in patients with schizophrenia.Semantic proximity
Incremental predictive value of genetic risk and functional brain connectivity in determining antipsychotic response in schizophrenia.Semantic proximity
Select a neighboring publication to make it the new centre.